Robert Besthof - Interim CEO at NRX Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO
Issuer Symbol
NRXP, NRXPW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Besthof since 13 Feb 2025

Holdings reported by Robert Besthof for NRX Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (Right to buy) 247,200 $49,440 $0.2000 16 Aug 2021 Direct Common Stock
Common Stock 23,710 $7,585 $0.3199 15 Sep 2021 Direct
Employee Stock Option 347,200 08 Mar 2022 Direct Common Stock
Restricted Stock Units 36,290 16 Aug 2021 Direct Common Stock

Transactions reported by Robert Besthof for NRX Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.